Table 1.
Summary of the patient's clinicopathological features and immunostaining findings in solid cell nests
| Case | A/S | T3, T4, TSH | PD | Main cells | C cells | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| p63 | bcl-2 | CK19 | GAL-3 | TG | TTF-1* | CT | p63 | bcl-2 | CK19 | GAL-3 | TG | TTF-1 | CT | ||||
| 1 | 64/F | WNL | NH | + | + | + | + | − | − | − | − | − | - | + | − | + | + |
| 2 | 45/M | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
| 3 | 43/F | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
| 4 | 36/F | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
| 5 | 70/F | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
| 6 | 37/F | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
| 7 | 44/M | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
| 8 | 69/F | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
| 9 | 62/F | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
| 10 | 46/F | WNL | NH | + | + | + | + | − | − | − | − | − | − | + | − | + | + |
WNL within normal limits, PD pathological diagnosis, A age (years)/S sex (F female, M male), * 30 % of main cells shown positive immunoreactions, CK 19 cytokeratin 19, GAL-3 galectin-3, TTF-1 thyroid transcription factor, TG thyroglobulin, CT calcitonin